Evidence map›Paper›PMID 32195234›Full record

ArticleFrontiers in bioengineering and biotechnology2020

Innocenzo Muzzalupo, Giuliana Badolati, Adriana Chiappetta, Nevio Picci, Rita Muzzalupo

Open access · goldAbstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
5.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. CD96 as a Potential Immune Regulator in Cancers.International journal of molecular sciences · 2023
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Innocenzo MuzzalupoDipartimento di Farmacia, Scienze della Salute e della Nutrizione - Universitá della Calabria (DFSSN-UNICAL), Ed. Polifunzionale, Arcavacata di Rende (CS), Rende, Italy.
Giuliana BadolatiDipartimento di Farmacia, Scienze della Salute e della Nutrizione - Universitá della Calabria (DFSSN-UNICAL), Ed. Polifunzionale, Arcavacata di Rende (CS), Rende, Italy.
Adriana ChiappettaDipartimento di Biologia, Ecologia e Scienza della Terra, Università della Calabria, Arcavacata di Rende, Italy.
Nevio PicciDipartimento di Farmacia, Scienze della Salute e della Nutrizione - Universitá della Calabria (DFSSN-UNICAL), Ed. Polifunzionale, Arcavacata di Rende (CS), Rende, Italy.
Rita MuzzalupoDipartimento di Farmacia, Scienze della Salute e della Nutrizione - Universitá della Calabria (DFSSN-UNICAL), Ed. Polifunzionale, Arcavacata di Rende (CS), Rende, Italy.
University of Calabria · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Olive leaf extract is characterized by a high content of phenols and flavonoids (oleuropein, luteolin, and their derivatives). These compounds are defined as secondary metabolites and exert such as anti-inflammatory, antioxidant, and antimicrobial activities. We investigated the

Indexed as

antifungal activitybiofungicidesnanoformulatesoleuropeinolive leaf extracts

Identifiers

PMID32195234
PMCPMC7062645
OpenAlexW3009642649

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.